3vt9: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
==Crystal structures of rat VDR-LBD with W282R mutation== | ==Crystal structures of rat VDR-LBD with W282R mutation== | ||
<StructureSection load='3vt9' size='340' side='right' caption='[[3vt9]], [[Resolution|resolution]] 2.35Å' scene=''> | <StructureSection load='3vt9' size='340' side='right'caption='[[3vt9]], [[Resolution|resolution]] 2.35Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
<table><tr><td colspan='2'>[[3vt9]] is a 2 chain structure with sequence from [ | <table><tr><td colspan='2'>[[3vt9]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Rattus_norvegicus Rattus norvegicus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3VT9 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=3VT9 FirstGlance]. <br> | ||
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=YI4:(1R,2Z,3R,5E,7E,9BETA,17BETA)-2-(2-HYDROXYETHYLIDENE)-17-[(2R)-6-HYDROXY-6-METHYLHEPTAN-2-YL]-9-(PROP-2-EN-1-YL)-9,10-SECOESTRA-5,7-DIENE-1,3-DIOL'>YI4</scene> | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.35Å</td></tr> | ||
<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=YI4:(1R,2Z,3R,5E,7E,9BETA,17BETA)-2-(2-HYDROXYETHYLIDENE)-17-[(2R)-6-HYDROXY-6-METHYLHEPTAN-2-YL]-9-(PROP-2-EN-1-YL)-9,10-SECOESTRA-5,7-DIENE-1,3-DIOL'>YI4</scene></td></tr> | |||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=3vt9 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3vt9 OCA], [https://pdbe.org/3vt9 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=3vt9 RCSB], [https://www.ebi.ac.uk/pdbsum/3vt9 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=3vt9 ProSAT]</span></td></tr> | |||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | |||
</table> | </table> | ||
== Function == | == Function == | ||
[ | [https://www.uniprot.org/uniprot/VDR_RAT VDR_RAT] Nuclear hormone receptor. Transcription factor that mediates the action of vitamin D3 by controlling the expression of hormone sensitive genes. Regulates transcription of hormone sensitive genes via its association with the WINAC complex, a chromatin-remodeling complex. Recruited to promoters via its interaction with the WINAC complex subunit BAZ1B/WSTF, which mediates the interaction with acetylated histones, an essential step for VDR-promoter association. Plays a central role in calcium homeostasis.<ref>PMID:17227670</ref> | ||
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
| Line 24: | Line 23: | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
[[Category: | [[Category: Large Structures]] | ||
[[Category: Ikura | [[Category: Rattus norvegicus]] | ||
[[Category: Ito | [[Category: Ikura T]] | ||
[[Category: Nakabayashi | [[Category: Ito N]] | ||
[[Category: Shimizu | [[Category: Nakabayashi M]] | ||
[[Category: Shimizu M]] | |||
Latest revision as of 12:37, 8 November 2023
Crystal structures of rat VDR-LBD with W282R mutation
| ||||||||||||